Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 54 days ago
Share
A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
207 patients around the world
Available in
Argentina, Chile
The overall study duration for each participant will be approximately up to 149 days.
Sanofi
2
Research sites
207
Patients around the world
This study is for people with
Psoriasis
Plaque psoriasis
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
View site
Bulnes 1937, CABA, Buenos Aires
Psoriahue Medicina Interdisciplinaria - CABA, Buenos Aires
Recruiting
View site
Bulnes 1937, CABA, Buenos Aires
Clínica Dermacross S.A. - Vitacura - Santiago
Recruiting
View site
Av. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881
Clínica Dermacross S.A. - Vitacura - Santiago
Recruiting
View site
Av. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881
See details
Contact us
Contact us
Study
SPECIFI-PSO
Sponsor
Sanofi
Conditions
Plaque psoriasis
Requirements
To 75 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06073119
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent